Redwood AI's Grand Ambitions Meet Reality as Shares Slide and Director Quits
13.06.2026 - 12:32:54 | boerse-global.de
For a company that just spent over a hundred thousand dollars telling the world its story, Redwood AI is getting a harsh reception from the market. Shares closed the week at 2.95 CAD, shedding 7.52 percent in a single session and wiping out 25.88 percent over the past five trading days. The annualized 30-day volatility stands at 130 percent — a figure that does little to inspire confidence among holders.
The selling pressure comes despite a fresh communications offensive. On June 12, Redwood AI disseminated an audio press release through NetworkNewsAudio, a service operated by InvestorBrandNetwork. The piece positioned the company at the intersection of artificial intelligence, defense technology, and quantum cryptography, targeting government and healthcare clients. StreetInsider carried the material with an explicit disclaimer that its own editorial team had no involvement.
That media push is part of a broader paid campaign. On May 26, Redwood AI signed a contract with InvestorBrandNetwork worth 114,000 US dollars in cash, running through September 2026. The agreement covers distribution across more than 75 investor-focused brands and over 5,000 syndication partners. No stock was involved in the payment.
Should investors sell immediately? Or is it worth buying Redwood AI?
Operationally, the company can point to a handful of initiatives, but none have yet generated binding revenue. The National Research Council of Canada has pledged advisory services and funding of up to 240,000 CAD under the Industrial Research Assistance Program for Project Q-SAFE. That initiative uses AI and quantum-optimization methods to classify hazardous chemicals, with applications in defense and security.
Elsewhere, Redwood AI signed a non-binding letter of intent on May 28 to acquire Quantum.IQ, a Vancouver-based firm specializing in AI-powered quantum cryptography. The deal contemplates up to 7 million shares upon closing, with another 7 million tied to milestone achievements — all subject to escrow conditions. A separate collaboration with Resilience Biosciences focuses on AI-driven computational chemistry for small-molecule development.
The week also brought an Africa-focused venture and an unexplained board departure. On June 11, the company inked a non-binding letter of intent with Dr. Placide Sesonga of the University of Global Health Equity in Rwanda. The plan targets AI-powered outbreak detection in Central and East Africa. But the agreement is explicitly non-binding; separate follow-up contracts will be needed for any concrete progress. That same day, Graydon Bensler resigned from the board with immediate effect. The company offered no reason for his exit.
Investors are left weighing a steady stream of press releases against a thin pipeline of enforceable contracts. The company reported no new lawsuits, no debt issuances, and issued 180,800 new shares from option exercises in its latest monthly disclosure. The narrative — AI, quantum security, defense — is ambitious, but the market is demanding evidence of customer traction, funded milestones, or binding agreements before it buys in. Until those appear, even a six-figure PR budget may do little to arrest the slide.
Ad
Redwood AI Stock: New Analysis - 13 June
Fresh Redwood AI information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
